Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
C16orf95 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TPM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANKRD10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FLJ37453 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
SPAG9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LUC7L2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FOXD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CECR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HLA-DPA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
THEMIS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CX3CR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SEC11C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRIM69 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SUPT20H - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PDIA4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
POLE2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FERMT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLEKHA8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MEIS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DUSP6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on